Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin Doublets in Advanced Cervical Cancer
NCT00064077Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- May 2003
- Primary completion
- Jan 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of vinorelbine, gemcitabine, topotecan liposome in Cervical Cancer (CC), sponsored by GOG Foundation. Started May 2003; status: completed.
02
Drugs
vinorelbinegemcitabinetopotecan liposome
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00064077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064077.